Developer docs
API playgroundTry for free, no card

Search company profiles

Sharklet Technologies

Full company profile

uuid000adyw

Namestring
Sharklet Technologies
Legal namestring
Sharklet Technologies, Inc.
Websiteurl
sharklet.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Sharklet Technologies, Inc. is a privately held biotechnology company headquartered in Aurora, Colorado (12635 E Montview Blvd, #211), founded in 2007. The company develops and commercializes the Sharklet micropattern, a proprietary surface technology inspired by the dermal denticles of sharkskin. The pattern is composed of millions of microscopic features arranged in a diamond geometry that physically inhibits bacteria from attaching, colonizing, and forming biofilms without the use of chemical antimicrobial agents or toxic additives. The technology is protected by multiple patents and has been independently tested by third-party laboratories in the United States, Europe, and Asia, with reported reductions of over 90% in bacterial transfer versus smooth surfaces.

The company's commercial product portfolio falls into three categories: (1) SharkletShield Germ Barrier Film — a peel-and-stick adhesive film applied to high-touch environmental surfaces in hospitality, education, transportation, commercial real estate, and restroom settings; (2) consumer products, including a Sharklet-patterned yoga mat; and (3) medical devices, specifically a Foley Urinary Catheter and an Endotracheal Tube, both incorporating the micropattern to reduce hospital-acquired infections. Sharklet monetizes through direct e-commerce sales (shop.sharklet.com), direct enterprise sales to healthcare and institutional customers, and an OEM/integration program that licenses the micropattern into partner products across a range of materials. Pricing is quote-based and not publicly disclosed; film is recommended for replacement on a roughly 90-day cycle.

The company operates with a small team (11–50 employees) and has been featured in major outlets including the New York Times, Forbes, Wired, the Washington Post, PBS NewsHour, and the Atlantic. Cumulative disclosed funding is approximately $3.7 million, sourced primarily from small grants and one early round, with the most recent funding event recorded in 2014. No current management roster beyond the co-founder/CTO and CFO is publicly listed, and ownership, investor base, and revenue figures are not disclosed in available materials.

Short descriptiontext

Sharklet Technologies is a private Aurora, Colorado-based biotech firm that commercializes a patented shark-skin-inspired micropattern inhibiting bacterial attachment on surfaces without chemicals. It sells adhesive film, consumer goods, and FDA-cleared medical devices to healthcare, hospitality, education, and transportation customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAurora, United States
HQ citystring
Aurora
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
antimicrobial surface technology, biomimetic material science, infection control products, medical device coatings, antibacterial surface films
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Antimicrobial Surface Technology
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1SharkletShield Film Sales
TypeOne Time License
Description

Sale of adhesively backed SharkletShield film products for application to high-touch surfaces in commercial and consumer settings. Films are sold directly through e-commerce and to enterprise customers.

sharklet.com
2Medical Device Products
TypeHardware Sales
Description

Sale of medical products incorporating Sharklet technology including Foley Urinary Catheter and Endotracheal Tube for healthcare settings.

sharklet.com
3Consumer Products
TypeHardware Sales
Description

Sale of consumer products including yoga mats with Sharklet technology through e-commerce channels.

sharklet.com
4Technology Licensing and Integration
TypeLicensing Royalties
Description

Working with companies to incorporate Sharklet technology into existing products and product lines. The micropattern can be added into existing products in a wide variety of materials.

sharklet.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1SharkletShield
Description

Adhesive film product line featuring the Sharklet micropattern for application to high-touch surfaces to inhibit bacterial growth.

sharklet.com
Core offering1 text field

Sharklet Technologies manufactures and licenses surface technologies based on a proprietary shark skin-inspired micropattern that inhibits bacterial colonization and biofilm formation without chemical antimicrobials. Its offerings span protective films, medical devices, and consumer goods designed to reduce microbial transfer in healthcare, hospitality, education, transportation, and consumer environments. The company also licenses its micropattern platform to OEMs for integration into third-party products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 90% less bacterial transfer on Sharklet surfaces compared to smooth surfaces
+1 more record
Product overview1 text field

Sharklet Technologies offers a family of products built around its patented Sharklet micropattern technology - a physical surface texture inspired by shark skin denticles that inhibits bacterial growth through pattern alone without toxic chemicals. The portfolio consists of SharkletShield Germ Barrier Film (adhesive film for high-touch surfaces), Sharklet Yoga Mat (consumer wellness product), and two FDA-cleared medical devices (Foley Urinary Catheter and Endotracheal Tube) for healthcare settings. All products share the core Sharklet micropattern technology but are tailored for different applications - film and mat for consumer/commercial surfaces, and catheters/tubes for medical device applications.

Product and service5 records
1SharkletShield Germ Barrier Film
CategoryProtective Surface Films
Description

Adhesive-backed protective film featuring the Sharklet micropattern that is applied to high-touch surfaces in commercial environments to inhibit bacterial transfer without chemical biocides or disinfectants. Designed for facility managers and procurement teams in hospitality, education, healthcare, transportation, and commercial real estate.

2Sharklet Yoga Mat
CategoryConsumer Goods
Description

A textured yoga mat produced with Sharklet's shark skin-inspired micropattern surface intended to inhibit bacterial buildup between cleanings. Sold direct-to-consumer through the Sharklet online store.

3Sharklet Foley Urinary Catheter
CategoryMedical Devices
Description

An indwelling Foley urinary catheter whose outer surface is patterned with Sharklet's proprietary micropattern to inhibit bacterial colonization and reduce catheter-associated urinary tract infections. Targeted at hospitals, infection control teams, and medical device distributors.

4Sharklet Endotracheal Tube
CategoryMedical Devices
Description

Endotracheal tubing whose surface features the Sharklet micropattern, intended to inhibit bacterial colonization associated with ventilator-associated pneumonia. Aimed at ICU and anesthesiology departments in hospitals and at medical device OEMs.

5Sharklet Technology Partner Integration
CategoryTechnology Licensing
Description

A licensing and integration offering that enables manufacturers to apply the Sharklet micropattern to their own products (such as medical devices or consumer goods) for bacterial-inhibiting properties. Designed for OEM partners, medical device manufacturers, and product developers.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthers
Description

Located near the University of Colorado Anschutz Medical Campus, Sharklet benefits from proximity to academic medical research environment.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German antimicrobial technology company offering surface coatings and additives (including silver-ion based) that inhibit bacterial growth on materials. Directly comparable as a competing antimicrobial surface technology provider targeting similar medical device and consumer product integrations.

TypeDirect peer
Description

Provider of built-in antimicrobial technologies (silver and copper-ion based) that inhibit bacterial growth on products and surfaces. Comparable because both companies sell antimicrobial efficacy into OEM product integration and surface-protection use cases across consumer and healthcare markets.

TypeDirect peer
Description

Antimicrobial copper-based technology company embedding copper into surfaces, textiles, and polymers to inhibit bacteria, fungi, and viruses. Directly comparable to Sharklet as a competing non-traditional (copper-based vs. pattern-based) antimicrobial mechanism targeting similar surface-protection applications.

TypeDirect peer
Description

Swedish medtech company applying a noble metal alloy coating to medical devices (catheters, endotracheal tubes, urinary catheters) to reduce hospital-acquired infections. Highly comparable to Sharklet's medical device business line and a direct competitor in coated infection-prevention devices.

TypeDirect peer
Description

Canadian medical device company specializing in antimicrobial coatings and infection prevention technologies for wound care and medical devices. Comparable because it sells antimicrobial surface technologies specifically into hospital infection-prevention applications, mirroring Sharklet's clinical go-to-market.

TypeBroad incumbent
Description

Largest branded built-in antimicrobial product protection provider, offering chemistry-based antimicrobial additives integrated into consumer and industrial products. A broader incumbent in the same antimicrobial surface space, though its chemistry-based mechanism contrasts with Sharklet's physical pattern approach.

TypeBroad incumbent
Description

Provider of surface modification coatings and drug-delivery technologies for medical devices. Comparable as a medical device surface coating specialist serving similar OEMs and catheter manufacturers, though with a broader portfolio beyond antimicrobial functionality.

TypeEmerging player
Description

Finnish startup developing polymer-based antimicrobial technology that can be incorporated into coatings, plastics, and textiles. Comparable as an emerging antimicrobial technology player with similar OEM integration value proposition, though at an earlier commercial stage.

TypeBroad incumbent
Description

Biomedical materials business (part of dsm-firmenich) that develops antimicrobial and biocompatible coatings for medical devices including implants and catheters. Comparable because it sells antimicrobial surface technology into the same hospital infection-prevention market.

TypeOthers
Description

Provider of parylene and other conformal coatings used in medical device surface modification, including antimicrobial applications. Comparable as a precision surface technology provider serving medical device OEMs with protective and functional coatings.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sharklet Technologies

Antimicrobial Surface Technologysharklet.com

Sharklet Technologies is a private Aurora, Colorado-based biotech firm that commercializes a patented shark-skin-inspired micropattern inhibiting bacterial attachment on surfaces without chemicals. It sells adhesive film, consumer goods, and FDA-cleared medical devices to healthcare, hospitality, education, and transportation customers.

What Sharklet Technologies does

Sharklet Technologies, Inc. is a privately held biotechnology company headquartered in Aurora, Colorado (12635 E Montview Blvd, #211), founded in 2007. The company develops and commercializes the Sharklet micropattern, a proprietary surface technology inspired by the dermal denticles of sharkskin. The pattern is composed of millions of microscopic features arranged in a diamond geometry that physically inhibits bacteria from attaching, colonizing, and forming biofilms without the use of chemical antimicrobial agents or toxic additives. The technology is protected by multiple patents and has been independently tested by third-party laboratories in the United States, Europe, and Asia, with reported reductions of over 90% in bacterial transfer versus smooth surfaces.

The company's commercial product portfolio falls into three categories: (1) SharkletShield Germ Barrier Film — a peel-and-stick adhesive film applied to high-touch environmental surfaces in hospitality, education, transportation, commercial real estate, and restroom settings; (2) consumer products, including a Sharklet-patterned yoga mat; and (3) medical devices, specifically a Foley Urinary Catheter and an Endotracheal Tube, both incorporating the micropattern to reduce hospital-acquired infections. Sharklet monetizes through direct e-commerce sales (shop.sharklet.com), direct enterprise sales to healthcare and institutional customers, and an OEM/integration program that licenses the micropattern into partner products across a range of materials. Pricing is quote-based and not publicly disclosed; film is recommended for replacement on a roughly 90-day cycle.

The company operates with a small team (11–50 employees) and has been featured in major outlets including the New York Times, Forbes, Wired, the Washington Post, PBS NewsHour, and the Atlantic. Cumulative disclosed funding is approximately $3.7 million, sourced primarily from small grants and one early round, with the most recent funding event recorded in 2014. No current management roster beyond the co-founder/CTO and CFO is publicly listed, and ownership, investor base, and revenue figures are not disclosed in available materials.

Sharklet Technologies firmographics

Firmographics
Name
Sharklet Technologies
Legal name
Sharklet Technologies, Inc.
Website
https://sharklet.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Short description
Sharklet Technologies is a private Aurora, Colorado-based biotech firm that commercializes a patented shark-skin-inspired micropattern inhibiting bacterial attachment on surfaces without chemicals. It sells adhesive film, consumer goods, and FDA-cleared medical devices to healthcare, hospitality, education, and transportation customers.
Ownership category
akta.pro rank

Where Sharklet Technologies is headquartered

Location

Headquarters

HQ city
Aurora
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Sharklet Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. SharkletShield Film Sales: Sale of adhesively backed SharkletShield film products for application to high-touch surfaces in commercial and consumer settings. Films are sold directly through e-commerce and to enterprise customers.
  2. Medical Device Products: Sale of medical products incorporating Sharklet technology including Foley Urinary Catheter and Endotracheal Tube for healthcare settings.
  3. Consumer Products: Sale of consumer products including yoga mats with Sharklet technology through e-commerce channels.
  4. Technology Licensing and Integration: Working with companies to incorporate Sharklet technology into existing products and product lines. The micropattern can be added into existing products in a wide variety of materials.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Sharklet Technologies product offering

Product offering

Core offering

Sharklet Technologies manufactures and licenses surface technologies based on a proprietary shark skin-inspired micropattern that inhibits bacterial colonization and biofilm formation without chemical antimicrobials. Its offerings span protective films, medical devices, and consumer goods designed to reduce microbial transfer in healthcare, hospitality, education, transportation, and consumer environments. The company also licenses its micropattern platform to OEMs for integration into third-party products.

Product overview

Sharklet Technologies offers a family of products built around its patented Sharklet micropattern technology - a physical surface texture inspired by shark skin denticles that inhibits bacterial growth through pattern alone without toxic chemicals. The portfolio consists of SharkletShield Germ Barrier Film (adhesive film for high-touch surfaces), Sharklet Yoga Mat (consumer wellness product), and two FDA-cleared medical devices (Foley Urinary Catheter and Endotracheal Tube) for healthcare settings. All products share the core Sharklet micropattern technology but are tailored for different applications - film and mat for consumer/commercial surfaces, and catheters/tubes for medical device applications.

Differentiator

Problem solved

Functional benefit

Brands

  • SharkletShield: Adhesive film product line featuring the Sharklet micropattern for application to high-touch surfaces to inhibit bacterial growth.

Products and services

  • SharkletShield Germ Barrier Film Adhesive-backed protective film featuring the Sharklet micropattern that is applied to high-touch surfaces in commercial environments to inhibit bacterial transfer without chemical biocides or disinfectants. Designed for facility managers and procurement teams in hospitality, education, healthcare, transportation, and commercial real estate.
  • Sharklet Yoga Mat A textured yoga mat produced with Sharklet's shark skin-inspired micropattern surface intended to inhibit bacterial buildup between cleanings. Sold direct-to-consumer through the Sharklet online store.
  • Sharklet Foley Urinary Catheter An indwelling Foley urinary catheter whose outer surface is patterned with Sharklet's proprietary micropattern to inhibit bacterial colonization and reduce catheter-associated urinary tract infections. Targeted at hospitals, infection control teams, and medical device distributors.
  • Sharklet Endotracheal Tube Endotracheal tubing whose surface features the Sharklet micropattern, intended to inhibit bacterial colonization associated with ventilator-associated pneumonia. Aimed at ICU and anesthesiology departments in hospitals and at medical device OEMs.
  • Sharklet Technology Partner Integration A licensing and integration offering that enables manufacturers to apply the Sharklet micropattern to their own products (such as medical devices or consumer goods) for bacterial-inhibiting properties. Designed for OEM partners, medical device manufacturers, and product developers.

Quantifiable outcome

  • Over 90% less bacterial transfer on Sharklet surfaces compared to smooth surfaces
  • +1 more outcomes

Companies that use Sharklet Technologies

Customer profile

Named customers5 records

Segments6 records

Ideal customer profiles6 records

Sharklet Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Sharklet Technologies partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Sharklet Technologies competitors and assessment

Company assessment

Direct peers

  • Bio-Gate AG: German antimicrobial technology company offering surface coatings and additives (including silver-ion based) that inhibit bacterial growth on materials. Directly comparable as a competing antimicrobial surface technology provider targeting similar medical device and consumer product integrations.
  • Sciessent (Agion): Provider of built-in antimicrobial technologies (silver and copper-ion based) that inhibit bacterial growth on products and surfaces. Comparable because both companies sell antimicrobial efficacy into OEM product integration and surface-protection use cases across consumer and healthcare markets.
  • Cupron: Antimicrobial copper-based technology company embedding copper into surfaces, textiles, and polymers to inhibit bacteria, fungi, and viruses. Directly comparable to Sharklet as a competing non-traditional (copper-based vs. pattern-based) antimicrobial mechanism targeting similar surface-protection applications.
  • Bactiguard: Swedish medtech company applying a noble metal alloy coating to medical devices (catheters, endotracheal tubes, urinary catheters) to reduce hospital-acquired infections. Highly comparable to Sharklet's medical device business line and a direct competitor in coated infection-prevention devices.
  • Covalon Technologies: Canadian medical device company specializing in antimicrobial coatings and infection prevention technologies for wound care and medical devices. Comparable because it sells antimicrobial surface technologies specifically into hospital infection-prevention applications, mirroring Sharklet's clinical go-to-market.

Broad incumbents

  • Microban International: Largest branded built-in antimicrobial product protection provider, offering chemistry-based antimicrobial additives integrated into consumer and industrial products. A broader incumbent in the same antimicrobial surface space, though its chemistry-based mechanism contrasts with Sharklet's physical pattern approach.
  • Surmodics: Provider of surface modification coatings and drug-delivery technologies for medical devices. Comparable as a medical device surface coating specialist serving similar OEMs and catheter manufacturers, though with a broader portfolio beyond antimicrobial functionality.
  • DSM Biomedical: Biomedical materials business (part of dsm-firmenich) that develops antimicrobial and biocompatible coatings for medical devices including implants and catheters. Comparable because it sells antimicrobial surface technology into the same hospital infection-prevention market.

Emerging players

  • Nolla Antimicrobial: Finnish startup developing polymer-based antimicrobial technology that can be incorporated into coatings, plastics, and textiles. Comparable as an emerging antimicrobial technology player with similar OEM integration value proposition, though at an earlier commercial stage.

Others

  • Specialty Coating Systems (SCS): Provider of parylene and other conformal coatings used in medical device surface modification, including antimicrobial applications. Comparable as a precision surface technology provider serving medical device OEMs with protective and functional coatings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Sharklet Technologies social profiles

Digital presence

Sharklet Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sharklet Technologies leadership team

Management profile

Number of profiles

Profiles2 records

Sharklet Technologies funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sharklet Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sharklet Technologies

What does Sharklet Technologies do?

Sharklet Technologies manufactures and licenses surface technologies based on a proprietary shark skin-inspired micropattern that inhibits bacterial colonization and biofilm formation without chemical antimicrobials. Its offerings span protective films, medical devices, and consumer goods designed to reduce microbial transfer in healthcare, hospitality, education, transportation, and consumer environments. The company also licenses its micropattern platform to OEMs for integration into third-party products.

Is Sharklet Technologies a public or private company?

Sharklet Technologies is a private company. It is classified as unknown and is currently operating.

When was Sharklet Technologies founded?

Sharklet Technologies was founded in 2007. It employs 1 to 10 people.

Where is Sharklet Technologies based?

Sharklet Technologies is headquartered in Aurora, United States, in the North America region.

How does Sharklet Technologies make money?

Four revenue lines are on record. SharkletShield Film Sales are the primary driver. The others are medical Device Products, consumer Products and technology Licensing and Integration.

Who are Sharklet Technologies's main competitors?

Direct peers on record are Bio-Gate AG, Sciessent (Agion), Cupron, Bactiguard and Covalon Technologies. Broad incumbents are Microban International, Surmodics and DSM Biomedical. Nolla Antimicrobial is listed as an emerging player. Specialty Coating Systems (SCS) is listed as an others.

Does Sharklet Technologies have an API?

No public API is recorded for Sharklet Technologies.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Grand View ResearchBiomimetic Packaging Materials Market Size Report, 2033A market research report values the global biomimetic packaging materials market at USD 1.8 billion in 2025, projected to reach USD 3.7 billion by 2033 at a 9.8% CAGR. Asia Pacific led with 36.5% of revenue in 2025, while biopolymer-based materials, films & flexible sheets, and food & beverage were the largest segments. The report profiles Sharklet Technologies, Lotus Leaf Coatings, Graham Packaging, Braskem/Cazoolo and Amazu Biomimicry.DatainteloSharkskin-Inspired Drag-Reducing Coatings Market Research Report 2033The global sharkskin-inspired drag-reducing coatings market, valued at USD 812 million in 2024, is projected to grow at a CAGR of 17.2% through 2033, reaching an estimated USD 2,655 million. This expansion is primarily driven by increasing demand for energy efficiency and sustainability across marine, aerospace, and automotive sectors, alongside advancements in nanotechnology and materials science. Key players such as Sharklet Technologies, BASF SE, and AkzoNobel are leading innovation efforts to enhance coating performance and durability.Business InsiderWhy shark scales might be key to helping stop bacterial spreadSharklet Technologies has developed a film mimicking sharkskin's dermal denticles to prevent bacterial attachment. The pattern reduces touch transfer of bacteria and fungi by over 95% and viruses by 80-85%. It is being applied to high-touch surfaces like elevator buttons and handrails.TechCrunchWhy engineers are looking to animals for new technologyEngineers and researchers across multiple institutions are increasingly turning to animal biology for inspiration in developing new technologies, a field known as biomimicry. The article profiles several examples including MIT's Cheetah 3 rescue robot designed to navigate dangerous terrain, Sharklet (a company founded in 2007 using shark-scale patterns to create non-toxic medical instruments), and Boston Dynamics' SpotMini robot which entered pre-production with plans for 2019 commercialization. Experts argue this bio-inspired approach is becoming essential for addressing real-world challenges in disaster response, healthcare, and elderly care.PR NewswireSappi's Neoterix™ ST Wins interzum 2017 Intelligent Material & Design AwardSappi North America's Neoterix ST release paper won interzum 2017's intelligent material & design award. The paper, developed with Sharklet Technologies, resists bacterial attachment without toxic additives. Sappi hopes the recognition will inspire designers and manufacturers to adopt its functional design.PR NewswireNeoterix™ ST de Sappi Obtiene el Premio interzum 2017 Material y Diseño InteligenteSappi North America received the Intelligent Material & Design Award at interzum 2017 for its Neoterix™ ST adhesive paper, a material featuring natural bacterial resistance. This recognition stems from a licensing collaboration with Sharklet Technologies to incorporate Sharklet™ microtexture into Sappi's products. The award highlights the material's potential to improve health and safety in homes and offices by preventing bacterial growth without toxic additives.PR NewswireSappis Neoterix™ ST ist Preisträger des interzum award: intelligent material & design 2017Sappi North America received the interzum award: intelligent material & design 2017 for its Neoterix™ ST release paper, recognized for its innovative antimicrobial properties without toxic additives. The product was developed through a 2016 exclusive global licensing agreement with Sharklet Technologies, whose Sharklet™ microtexture technology creates surfaces resistant to bacterial colonization. The award was presented by interzum, the world's leading trade fair for furniture production and interior design.PR NewswireNeoterix™ ST de Sappi remporte le prix interzum 2017 pour le matériel et la conception intelligentsSappi North America won the interzum 2017 Intelligent Material & Design Award at the world's largest furniture production trade fair for its Neoterix™ ST protective paper, the first protective paper to transmit natural bacteria resistance. Neoterix™ ST was developed through an exclusive global licensing partnership with Sharklet Technologies, which provides a revolutionary micro-texture surface designed to inhibit microorganism growth on various surfaces.PR NewswireSappi North America annonce Neoterix™ST, le premier papier antiadhésif commercial à haut brillant doté de la technologie antibactérienne Sharklet™Sappi North America signed an exclusive worldwide license with Sharklet Technologies to produce high-gloss antibacterial paper using Sharklet microtexture. The product, Neoterix ST, reduces surface contamination by up to 97% for MSSA and 94% for MRSA. Sappi plans to launch the product commercially in early 2017.PR NewswireSappi North America Announces Neoterix™ST, the First Commercial Casting and Release Paper with Sharklet™ Bacteria-Inhibition TechnologySappi North America entered an exclusive worldwide license with Sharklet Technologies to manufacture casting and release paper featuring Sharklet microtexture, the first such product to inhibit bacterial growth without toxic additives. The Sharklet microtexture reduced surface contamination of MSSA and MRSA by up to 97% and 94% respectively. Neoterix ST is expected to be commercially available globally in early 2017.